Skip to main content
Article thumbnail
Location of Repository

Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the “Magenta osteoarthritis study”

By M. Scarpellini, A. Lurati, G. Vignati, M. G. Marrazza, F. Telese, K. Re and A. Bellistri
Topics: Original Article
Publisher: Springer Milan
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2007). A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis-association with disease progression.
    2. (2004). A new marker for osteoarthritis: cross-sectional and longitudinal approach.
    3. (2001). Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis.
    4. (2007). Chondrocyte moves: clever strategies?
    5. (2007). Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies.
    6. (2007). DMOAD developments: present and future.
    7. (2007). Does subchondral bone tissue remodeling or cell function play a role in articular cartilage loss in osteoarthritis? Osteoarthritis Cartilage 15(Suppl):C3
    8. (2005). Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint localization and histological grading.
    9. (2002). Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration.
    10. (2002). Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study.
    11. (2006). Glucosamine, chondroitin sulphate, and the two in combination for painful knee osteoarthritis.
    12. (2008). Hand osteoarthritis and bone mineral density in postmenopausal women; clinical relevance to hand function, pain and disability.
    13. (2000). In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulphate. Clin Orthop Relat Res 381:229–240
    14. (2006). Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. Ann Rheum Dis 65:1639–1644
    15. (2006). Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis 65:354–359
    16. (2006). Nutriceutical for healthy joints.
    17. (2006). Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.
    18. (2006). Osteoporosis and bone metabolism in postmenopausal women with osteoarthritis of the hand.
    19. (1990). The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand.
    20. (1999). The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre-and perimenopausal women.
    21. (1963). The epidemiology of chronic rheumatism. In: Davis FA (ed) Atlas of standard radiographs of arthritis. vol II. Blackwell Scientific Publication,
    22. (2001). The morphology and selected biological properties of articular cartilage.
    23. (1995). The relationship between osteoarthritis of the hands,
    24. (2007). Therapeutic efficacy and safety of undenatured type II collagen singly or in combination with glucosamine and chondroitin in arthritic dogs.
    25. (2006). Urinary CTX-II and glucosyl-galactosyl-pyridinoline are associated with the presence and severity of radiographic knee osteoarthritis in men.
    26. (2005). Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    27. (2001). Use of undenatured type II collagen in the treatment of rheumatoid arthritis.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.